期刊文献+

胃癌组织中P16蛋白和VEGF蛋白的表达及临床意义 被引量:2

Expression of P16 and VEGF Proteins in Gastric Cancer and Its Clinical Significance
暂未订购
导出
摘要 目的探讨抑癌基因P16蛋白和VEGF蛋白在胃癌组织中的表达情况及与胃癌组织发生、发展的关系。方法用免疫组化Max VisionTM法对60例胃癌及癌旁组织检测P16蛋白和VEGF蛋白。结果 P16蛋白的总阳性率为63.33%(38/60,P<0.05),P16蛋白的阳性表达与胃癌组织的分化程度、癌组织的浸润程度、淋巴结有无转移及伴不伴有神经浸润有关。VEGF的总阳性率为61.67%(37/60,P<0.05),VEGF的阳性表达与胃癌组织的分化程度及浸润程度没有相关性,与淋巴结有无转移和伴不伴有神经浸润有关。结论 P16蛋白和VEGF蛋白与胃癌组织的发生、发展、预后关系密切,可作为胃癌患者术后预后、评估检测的指标。 Objective To explore the expression of P16 and VEGF proteins in the gastric cancer tissue and the relationship between their expression and the occurrence and development of gastric cancer. Methods The P16 and VEGF expression in 60 eases of gastric cancer and its adjacent tissue was detected by MaxVisionTM immunohistoehemieal method. Results The positive rate of P16 protein was 68.33(41/60, P〈 0.05 ), and the P16 protein expression was correlated with gastric cancer tissue differentiation, cancer infiltration, lymph node metastasis and nerve infiltration. The positive rate of VEGF was 61.67%(37/60, P〈0.05 ). The VEGF protein expression was not correlated with gastric cancer tissue differentiation and cancer infiltration, but was correlated with lymph node metastasis and nerve infiltration. Conclusion The expression of P16 and VEGF proteins is closely correlated with the occurrence,development and prognosis of gastric cancer,which can be used to evaluate the biological behavior and prognosis of gastric cancer.
作者 杨红
出处 《中国现代医生》 2010年第11期88-89,96,共3页 China Modern Doctor
关键词 胃癌 P16和VEGF蛋白 免疫组织化学 Gastric cancer P16 and VEGF proteins Immunohistochemistry
  • 相关文献

参考文献8

  • 1Lukas J,Angaard L,Strauss M,et al. Oncogenic aberrations of P16 and Cyclin D1 cooperate to deregulate G1 control[J]. Cancer Res,1995,55: 4818-4828.
  • 2Sherr CJ,Roberts JM. lnhibitors of mammalian G1 Cyclin-dependent Kinases[J]. Genes Dev, 1995,9 : 1149-1163.
  • 3Hunter T,Pines J. Cyclins and cancer:cyclin D and CDK inhibitors come of age[J]. Cell, 1994,79 : 573-582.
  • 4Motokura T, Arnold A.Cyclins and oncogenesis[J]. Biochem Biophys Acta, 1993,1155 : 63-78.
  • 5Marx J. New tumor surppressor may rival P53[J]. Science, 1994,264: 344.
  • 6Even ME,Sluss HK,Sheer CJ. Functional interactions of the pRb with marmnalia D-type Cyclins[J]. Cell, 1993,73 : 487.
  • 7楚广民,付秀虹,陈小兵,周辉,姜红光.VEGF、nm23表达及树突状细胞浸润与肺癌预后的相关性[J].中国误诊学杂志,2003,3(4):493-495. 被引量:11
  • 8唐朝晖,夏汉通,李海燕,江拥军,齐海智.VEGF在大肠癌中的表达及临床意义[J].中国误诊学杂志,2005,5(1):28-29. 被引量:4

二级参考文献12

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2[1]Restifo NP. Re-evaluating the mechanisms of immune privilege and tumor escape. Nat med, 2000,6(5) :493
  • 3[2]Folkman J,Klagsbrum M. Angiogenic factors. Scince, 1987,235(4787):442-447
  • 4[3]Shueiki D,Itin A, Soffer L,et al. Vascular endothelial growth factor induced by hgpoxia may mediate hgpoxia-initiated angiogenesis. Nature, 1992,359 (6398): 843-845
  • 5[4]Yamaguchi A, Urano T, coi T, et al. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma Cancer, 1994,73(9) :2280-2284
  • 6[5]Banchereau J, Steinman RM. Dendritic cells and the contol of immunity Nature, 1998,392 (6773) :245
  • 7[6]Wright-Browni V, Mcclain KL, Talpaz M, et al. Physiology and patho physiology of dendritic cells, Hum pathol, 1997; 28(5): 563
  • 8吴在德.外科学(全国高等医学院校教材)[M](第5版)[M].北京:人民卫生出版社,2001.530-532.
  • 9Ferrara N ,Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells[J]. Bioche m Biophys Res Com mun,1989,161(2):851 .
  • 10Anderson AR, Chaplain MA. Continuous and discrete mathematical models of tumor-induced angiogenesis [J]. Bull Math Biol,1998,60(5) :857.

共引文献11

同被引文献27

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部